165 related articles for article (PubMed ID: 9758342)
21. A non-isotopic nested polymerase chain reaction method to quantitate minimal residual disease in patients with non-Hodgkin's lymphoma.
Hétu F; Coutlée F; Roy DC
Mol Cell Probes; 1994 Dec; 8(6):449-57. PubMed ID: 7700265
[TBL] [Abstract][Full Text] [Related]
22. Detection and quantification of MBR/JH2 t(14;18) BCL-2 gene rearrangement in follicular lymphoma using a combined real-time polymerase chain reaction assay.
Csernák E; Tóth E; Melegh Z; Schneider T; Rosta A; Szentirmay Z
Haematologica; 2006 Jun; 91(6):858-9. PubMed ID: 16704964
[TBL] [Abstract][Full Text] [Related]
23. The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells.
McGregor DK; Keever-Taylor CA; Bredeson C; Schur B; Vesole DH; Logan B; Chang CC
Bone Marrow Transplant; 2005 Jun; 35(11):1049-54. PubMed ID: 15821762
[TBL] [Abstract][Full Text] [Related]
24. Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma.
Friedberg JW; Kim H; Li S; Neuberg D; Boyd K; Daley H; Fisher DC; Gribben JG; Spitzer T; Freedman AS
Bone Marrow Transplant; 2003 Oct; 32(7):681-6. PubMed ID: 13130315
[TBL] [Abstract][Full Text] [Related]
25. PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma.
Mahé B; Milpied N; Mellerin MP; Moreau P; Morineau N; Vigier M; Harousseau JL
Bone Marrow Transplant; 2003 Mar; 31(6):467-73. PubMed ID: 12665842
[TBL] [Abstract][Full Text] [Related]
26. Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations.
Negrin RS; Pesando J
J Clin Oncol; 1994 May; 12(5):1021-7. PubMed ID: 8164025
[TBL] [Abstract][Full Text] [Related]
27. Commercial LightCycler-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma.
Kornacker M; Kornacker B; Schmitt C; Leo E; Ho AD; Hensel M
Ann Hematol; 2009 Jan; 88(1):43-50. PubMed ID: 18636259
[TBL] [Abstract][Full Text] [Related]
28. Bcl-2 clearance: optimising outcomes in follicular non-Hodgkin's lymphoma.
Berinstein NL; Buckstein R; Imrie K; Spaner D; Mangel J; Tompkins K; Pennell N; Reis M; Pavlin P; Lima A; Couvadia A; Robinson J; Richardson P
Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S14-7. PubMed ID: 11840156
[TBL] [Abstract][Full Text] [Related]
29. Dynamics of circulating t(14;18)-positive cells during first-line and subsequent lines of treatment in follicular lymphoma.
Mandigers CM; Meijerink JP; van 't Veer MB; Mensink EJ; Raemaekers JM
Ann Hematol; 2003 Dec; 82(12):743-9. PubMed ID: 14513290
[TBL] [Abstract][Full Text] [Related]
30. Comparison of different strategies of molecular genetic monitoring following autologous stem cell transplantation in patients with follicular lymphoma.
von Neuhoff N; Dreger P; Suttorp M; Marget M; Kell S; Schmitz N
Bone Marrow Transplant; 1998 Jul; 22(2):161-6. PubMed ID: 9707024
[TBL] [Abstract][Full Text] [Related]
31. One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near?
Schmitt C; Grundt A; Buchholtz C; Scheuer L; Benner A; Hensel M; Ho AD; Leo E
Leuk Res; 2006 Dec; 30(12):1563-8. PubMed ID: 16530831
[TBL] [Abstract][Full Text] [Related]
32. Concurrent presence of both patient and donor t(14;18) in a follicular lymphoma patient after undergoing allogeneic BMT: implications for minimal residual disease detection post-transplant.
Rosenblum MD; Drobyski WR; Keever-Taylor C; Chang CC
Bone Marrow Transplant; 2003 May; 31(10):947-9. PubMed ID: 12748676
[TBL] [Abstract][Full Text] [Related]
33. Real-Time t(14;18)(q32;q21) PCR assay combined with high-resolution capillary electrophoresis: a novel and rapid approach that allows accurate quantitation and size determination of bcl-2/JH fusion sequences.
Sanchez-Vega B; Vega F; Hai S; Medeiros LJ; Luthra R
Mod Pathol; 2002 Apr; 15(4):448-53. PubMed ID: 11950920
[TBL] [Abstract][Full Text] [Related]
34. Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma.
Paszkiewicz-Kozik E; Kulik J; Fabisiewicz A; Tysarowski A; Kraszewska E; Siedlecki JA; Walewski J
Med Oncol; 2009; 26(1):16-21. PubMed ID: 18470485
[TBL] [Abstract][Full Text] [Related]
35. A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma.
Arcaini L; Orlandi E; Alessandrino EP; Iacona I; Brusamolino E; Bonfichi M; Bernasconi P; Calatroni S; Tenore A; Montanari F; Troletti D; Pascutto C; Regazzi M; Lazzarino M
Bone Marrow Transplant; 2004 Jul; 34(2):175-9. PubMed ID: 15170171
[TBL] [Abstract][Full Text] [Related]
36. Sensitive and reproducible detection of occult disease in patients with follicular lymphoma by PCR amplification of t(14;18) both pre- and post-treatment.
Berinstein NL; Jamal HH; Kuzniar B; Klock RJ; Reis MD
Leukemia; 1993 Jan; 7(1):113-9. PubMed ID: 8418370
[TBL] [Abstract][Full Text] [Related]
37. Histological conversion of follicular lymphoma with structural alterations of t(14;18) and immunoglobin genes.
Raghoebier S; Broos L; Kramer MH; van Krieken JH; Kluin-Nelemans JC; van Ommen GJ; Kluin P
Leukemia; 1995 Oct; 9(10):1748-55. PubMed ID: 7564520
[TBL] [Abstract][Full Text] [Related]
38. [Follicular lymphoma associated with t(14;18)(q32;q21) chromosome translocation and bcl-2 gene rearrangement: report of a case].
Nagai T; Koyama R; Sasagawa Y; Matsumoto S; Kohgo Y; Niitsu Y; Konn S
Rinsho Ketsueki; 1993 Feb; 34(2):137-42. PubMed ID: 8492410
[TBL] [Abstract][Full Text] [Related]
39. Autologous bone-marrow transplantation for Burkitt's lymphoma: marrow purging with anti-Y 29/55 monoclonal antibody and complement.
Baumgartner C; Delaleu B; Imbach P; Lüthy A; Odavic R; Brun del Re G; Bucher U; Forster HK; Hirt A; Wagner HP
IARC Sci Publ; 1985; (60):435-40. PubMed ID: 3905594
[TBL] [Abstract][Full Text] [Related]
40. Comparative preclinical study of three bone marrow purging methods using PCR evaluation of residual t(14;18) lymphoma cells.
Yerly-Motta V; Racadot E; Fest T; Bastard C; Ferrand C; Deschaseaux ML; Herve P
Leuk Lymphoma; 1996 Oct; 23(3-4):313-21. PubMed ID: 9031112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]